to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Angel investors are funding companies at the seed and start-up stage, as venture capitalists retreat from that market, says an angel investor and former entrepreneur.
Numerous factors affect how angels value a company. Primary are the strength of the management team and the size of the opportunity, or a company's potential to scale. Accompanying this article is a valuation worksheet that entrepreneurs can use to better understand what investors look for and to identify factors that can justify higher pre-money valuations. Investors will find it useful to compare companies and determine whether valuation should be higher or lower.
A highly successful angel investor and entrepreneur identifies and puts to the test a valuation calculator tool. He finds that it works very well, thank you. By answering twenty-five questions, entrepreneurs and investors arrive at valuations that can reasonably be used as a practical guide to investing.
This informative piece explains a well-known method that venture capitalists use to determine "post-money valuation," which is a company's valuation at the time of investment. Perhaps more important, it provides valuable insights into why the returns expected by investors are often perceived as "too high" by entrepreneurs.
Timothy C. Draper is the Founder and a Managing Director of Draper Fisher Jurvetson. He was instrumental in bringing viral marketing to web-based e-mail to geometrically spread the successes of Hotmail and YahooMail, and
the practice has been adopted as a standard marketing technique by countless businesses and organizations. Draper launched the DFJ Global Network, an international network of early-stage venture capital funds with offices in over 30 cities
around the globe. He also serves on the boards of Skype, SocialText, Project Y, MailFrontier and Chroma Graphics. He was an original investor in Parametric Technology (PMTC), Tumbleweed Communications (TMWD), Overture.com (OVER),
Digidesign (AVID), Preview Travel (TVLY), Four11 (YHOO), Combinet (CSCO), and Redgate (AOL). He also founded or co-founded Wasatch Ventures (Salt Lake City), Zone Ventures (LA), Draper Atlantic (Reston), Draper Triangle (Pittsburg),
Timberline Ventures (Portland), Polaris Fund (Anchorage), Draper Fisher Jurvetson Gotham (NYC) and DFJ Frontier (Sacramento and Santa Barbara). Draper has been recognized as a leader in entrepreneurship and venture capital through numerous
awards and honors, and he has frequent TV, radio, and headline appearances. He was number seven on Forbes? Midas List and number 52 on the list of the most influential Harvard Alumni. He was also named AlwaysOn Magazine?s number one top
venture capital dealmaker for 2008. Tim is the course creator and Chairman of BizWorld, a 501c3 organization built around simulated teaching of entrepreneurship and business to children. He holds a BS in Electrical Engineering from
Stanford University, and an MBA from Harvard Business School.
Steve Perricone is President, CEO, and Co-founder of BioFuelBox Corporation. And he has over 20 years experience in the technology industry, with over half of those years in start-up environments. Perricone was Vice
President of Worldwide Sales for SonicWALL, which he joined when it had less than 20 employees. Perricone was instrumental in the growth of the company, and expanded it to over 450 employees worldwide. He was directly responsible for
building the worldwide channel for SonicWALL?s security products from the product line?s inception in 1998. That successful channel and sales organization contributed to near immediate company profitability and aggregate revenues of over
$200 million in the first three years. Prior to SonicWALL, Perricone was a senior executive in two other technology start-ups - Network TeleSystems (acquired by Siemens) and Structured Internetworks. He is an alumnus of California State
What's the best strategy for developing and launching a new medical device? The uncertainty of the regulatory and reimbursement environment in the United States has made venture capitalists wary of investing in new medical device companies, but that doesn't mean all is lost.
A healthcare VC predicts that more DNA sequencing and the shift from patients to healthcare consumers, among other things, will rule the future of healthcare innovation.
London's Alternative Investment Market (AIM) is a credible alternative for U.S. companies looking for a market listing. As with any approach to IPO, U.S. companies should research AIM's advantages and disadvantages for listing compared with U.S. stock markets.
One of George Bush's most memorable lines was his complaint that the French had no word for "entrepreneur". Well, if Senator Dodd's new financial reform bill becomes law, we may well have the word, but no longer any need for it.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.